Search Results - "Lemons, Richard"

IMPROVEMENT ROUTINES: RESEARCH BY AND FOR PRACTITIONERS by Stevenson, Isobel, Lemons, Richard W.

“…The relationship between research and practice in K-12 is complicated and fraught. Research publications are unlikely to become more “user-friendly,” and…”
Get full text

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial by Grainger, John D, Dr, Locatelli, Franco, MD, Chotsampancharoen, Thirachit, MD, Donyush, Elena, MD, Pongtanakul, Bunchoo, MD, Komvilaisak, Patcharee, MD, Sosothikul, Darintr, MD, Drelichman, Guillermo, MD, Sirachainan, Nongnuch, MD, Holzhauer, Susanne, MD, Lebedev, Vladimir, MD, Lemons, Richard, MD, Pospisilova, Dagmar, MD, Ramenghi, Ugo, MD, Bussel, James B, MD, Bakshi, Kalpana K, MS, Iyengar, Malini, PhD, Chan, Geoffrey W, MD, Chagin, Karen D, MD, Theodore, Dickens, MD, Marcello, Lisa M, MS, Bailey, Christine K, PhD

“…Summary Background The thrombopoietin receptor agonist eltrombopag has been shown to be safe, tolerable, and effective for adults with chronic immune…”
Get full text

Neonatal hemolytic jaundice: morphologic features of erythrocytes that will help you diagnose the underlying condition by Christensen, Robert D, Yaish, Hassan M, Lemons, Richard S

“…Many cases of severe neonatal hyperbilirubinemia never have the underlying cause of the jaundice clearly identified. Thus they are said to have 'idiopathic'…”
Get more information

Neonatal nonimmune hemolytic anemia by Yaish, Hassan M, Christensen, Robert D, Lemons, Richard S

“…As in adults and older children, anemia in newborn infants can be the result of erythropoietic failure, hemorrhage, or hemolysis. When hemolysis is the prime…”
Get full text

Likelihood of Bone Recurrence in Prior Sites of Metastasis in Patients With High-Risk Neuroblastoma by Polishchuk, Alexei L., MD, PhD, Li, Richard, BS, Hill-Kayser, Christine, MD, Little, Anthony, BS, Hawkins, Randall A., MD, PhD, Hamilton, Jeffrey, BFA, Lau, Michael, BS, Tran, Hung Chi, MD, Strahlendorf, Caron, MB, BCh, Lemons, Richard S., MD, PhD, Weinberg, Vivian, PhD, Matthay, Katherine K., MD, DuBois, Steven G., MD, Marcus, Karen J., MD, Bagatell, Rochelle, MD, Haas-Kogan, Daphne A., MD

“…Purpose/Objectives Despite recent improvements in outcomes, 40% of children with high-risk neuroblastoma will experience relapse, facing a guarded prognosis…”
Get full text

Supportive care medications coinciding with chemotherapy among children with hematologic malignancy by Biltaji, Eman, Enioutina, Elena Y., Yellepeddi, Venkata, Rower, Joseph E., Sherwin, Catherine M. T., Ward, Robert M., Lemons, Richard S., Constance, Jonathan E.

“…Pharmacokinetic (PK) conflicts can arise between supportive care medications (SCM) and chemotherapy in children with hematologic malignancy (HM). In this…”
Get full text

Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review by Constance, Jonathan E, McFarland, Mary M, Casucci, Tallie, Deininger, Michael W, Enioutina, Elena Y, Job, Kathleen, Lemons, Richard S, Lim, Carol S, Ward, Robert M, Yellepeddi, Venkata, Watt, Kevin M

“…Numerous reports contend opioids can augment or inhibit malignancy. At present, there is no consensus on the risk or benefit posed by opioids on malignancy or…”
Get full text

Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B by Lemons, Richard, Wang, Michael, Curtin, Julie, Lepatan, Lynda Mae, Male, Christoph, Peyvandi, Flora, von Depka Prondzinski, Mario, Wang, Rongrong, McKeand, William, Seifert, Wilfried, Oldenburg, Johannes

“…Recombinant fusion protein linking coagulation factor IX (FIX) with albumin (rIX-FP) has been shown to be an effective, well-tolerated treatment for patients…”
Get full text

Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer by Rower, Joseph E, King, Amber D, Wilkins, Diana, Wilkes, Jacob, Yellepeddi, Venkata, Maese, Luke, Lemons, Richard S, Constance, Jonathan E

“…The therapeutic utility of in cancer is a topic of intense interest. Dronabinol is synthetic Δ -tetrahydrocannabinol (THC), the primary psychoactive component…”
Get more information

Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer by Olson, Jared, Mehra, Sonia, Hersh, Adam L, Thorell, Emily A, Stoddard, Gregory J, Maese, Luke, Barnette, Phillip E, Lemons, Richard S, Pavia, Andrew T, Knackstedt, Elizabeth D

“…Abstract Background Although febrile neutropenia (FN) is a frequent complication in children with cancer receiving chemotherapy, there remains significant…”
Get full text

Learning to Walk, Walking to Learn: Reconsidering the Walkthrough as an Improvement Strategy by Lemons, Richard W., Helsing, Deborah

“…School leaders desperate for strategies that will improve student learning have often opted to embrace strategies that they have observed being used…”
Get full text

High-Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population by BARNETTE, Phillip, SCHOLL, Rebecca, KELLER, Charles, BLANDFORD, Mary, BALLARD, Linda, TSODIKOV, Alexander, MAGEE, Jalene, WILLIAMS, Susana, ROBERTSON, Margaret, ALI-OSMAN, Francis, LEMONS, Richard

“…Polymorphisms of glutathione S -transferase (GST) enzymes have been correlated with altered risk of several cancers, as well as altered response and toxicity…”
Get full text

Low-grade myofibrosarcoma of the head and neck: importance of surgical therapy by Keller, Charles, Gibbs, Callie N, Kelly, Steven M, Haller, Jeffrey R, White, Keith S, Coffin, Cheryl M, Lemons, Richard S

Get full text

HIV Comorbid Infection and Liver-Directed AAV-Based Gene Therapy in Adults with Severe and Moderately Severe Hemophilia B: Efficacy and Safety Results from Phase 2b and the Pivotal Phase 3 HOPE-B Trials 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec by Pipe, Steven, Gomez, Esteban, Hermans, Cedric R., Giermasz, Adam, Kampmann, Peter, Lemons, Richard, Galante, Nicholas, LeQuellec, Sandra, Monahan, Paul

“…Introduction: People living with HIV represent an important subset within the hemophilia community. Concerns about increased hepatotoxicity of liver-directed…”
Get full text

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B by Pipe, Steven W., Leebeek, Frank W.G., Recht, Michael, Key, Nigel S., Castaman, Giancarlo, Miesbach, Wolfgang, Lattimore, Susan, Peerlinck, Kathelijne, Van der Valk, Paul, Coppens, Michiel, Kampmann, Peter, Meijer, Karina, O’Connell, Niamh, Pasi, K. John, Hart, Daniel P., Kazmi, Rashid, Astermark, Jan, Hermans, Cedric R.J.R., Klamroth, Robert, Lemons, Richard, Visweshwar, Nathan, von Drygalski, Annette, Young, Guy, Crary, Shelley E., Escobar, Miguel, Gomez, Esteban, Kruse-Jarres, Rebecca, Quon, Doris V., Symington, Emily, Wang, Michael, Wheeler, Allison P., Gut, Robert, Liu, Ying P., Dolmetsch, Ricardo E., Cooper, David L., Li, Yanyan, Goldstein, Brahm, Monahan, Paul E.

“…An AAV5 vector containing the factor IX Padua allele was administered to 54 men with hemophilia B. Factor IX expression increased to approximately 39% of…”
Get full text

Safety, dose, and timing of Reteplase in treating occluded central venous catheters in children with cancer by TERRILL, Kelly R, LEMONS, Richard S, GOLDSBY, Robert E

“…Recombinant tissue plasminogen activator, alteplase, began to be commonly used to restore the patency of occluded central venous catheters (CVCs) as urokinase…”
Get full text

Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B by O’Connell, Niamh, van der Valk, Paul, Le Quellec, Sandra, Gomez, Esteban, Monahan, Paul E., Crary, Shelley E., Coppens, Michiel, Lemons, Richard, Castaman, Giancarlo, Klamroth, Robert, Symington, Emily, Quon, Doris V., Kampmann, Peter

“…Little information regarding the management of invasive procedures in people with hemophilia B (HB) after undergoing gene therapy is available. Here, we report…”
Get full text

Long-Term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption and Safety of Hemophilia B Gene Therapy: Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec in Adult Patients with Severe or Moderately Severe Hemophilia B by Pipe, Steven, van der Valk, Paul, Verhamme, Peter, Kampmann, Peter, Leebeek, Frank W.G., Coppens, Michiel, Meijer, Karina, Raheja, Priyanka, Key, Nigel S., Visweshwar, Nathan, Young, Guy, Lemons, Richard S., Klamroth, Robert, Miesbach, Wolfgang, Astermark, Jan, O'Connell, Niamh, Kazmi, Rashid Saeed, Galante, Nicholas, LeQuellec, Sandra, Monahan, Paul, Hermans, Cedric R.

“…Introduction: Etranacogene dezaparvovec (formerly AMT-061) is the first approved gene therapy for hemophilia B in the US and Europe. It is an adeno-associated…”
Get full text

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies by Pipe, Steven W., Recht, Michael, Key, Nigel S., Leebeek, Frank W.G., Castaman, Giancarlo, Lattimore, Susan U., Van Der Valk, Paul, Peerlinck, Kathelijne, Coppens, Michiel, O'Connell, Niamh, Pasi, John, Kampmann, Peter, Meijer, Karina, von Drygalski, Annette, Young, Guy, Hermans, Cedric, Astermark, Jan, Klamroth, Robert, Lemons, Richard S., Visweshwar, Nathan, Crary, Shelley, Kazmi, Rashid, Symington, Emily, Escobar, Miguel A., Gomez, Esteban, Kruse-Jarres, Rebecca, Kotowski, Adam, Quon, Doris, Wang, Michael, Wheeler, Allison P., Sawyer, Eileen K, Verweij, Stephanie, Colletta, Valerie, Bajma, Naghmana, Gut, Robert, Miesbach, Wolfgang A.

“…Background: Etranacogene dezaparvovec is an investigational gene therapy for hemophilia B (HB) comprising an adeno-associated virus serotype 5 (AAV5) vector…”
Get full text

Reduction in Inpatient Central Line Associated Blood Stream Infection Post Implementation of Bundled Care Measures in Patients with Benign and Malignant Hematological Conditions in a Single Pediatric Institution by Verma, Anupam, Linder, Lauri, Knackstedt, Elizabeth D, Gerdy, Cheryl, Abouzelof, Rouett, Lemons, Richard S.

“…Background: Central line associated blood stream infections (CLABSIs) are a significant source of morbidity, mortality and cost for pediatric…”
Get full text